Medigene AG is a publicly listed (Frankfurt: MDG1, prime standard) biotechnology company headquartered in Martinsried near Munich, Germany. The company is developing highly innovative, complementary treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. Medigene concentrates on the development of personalized T cell-based immunotherapies. Medigene is developing innovative drugs for the treatment of cancer and autoimmune diseases, with the aim of providing better treatment options for patients with serious diseases. The company concentrates on the development of personalized immunotherapies with focus on hematological malignancies. Through scientific innovation and targeted use of resources, Medigene strives to create sustainable value that will benefit both patients and shareholders.
Mai multe informatii http://www.medigene.com/company/company-profile
S.M.B. is a Belgian based pharmaceutical company with global ambitions. Its objective is to become a leading European player in the field of oral and pulmonary drug delivery systems by being an innovative actor in the pharmaceutical industry.
Together with its exclusive partners, S.M.B. Technology S.A. (Contract Manufacturing) and GALEPHAR M/F (Contract R&D), Laboratoires SMB’s activity embraces a large spectrum of competences in initial R&D, continuous R&D, Clinical Trials, Analytics, production, Regulatory Affairs and Marketing, supporting a pipeline of in-house formulations. The activities of S.M.B. involve new formulations and/or new chemical entities, clinical testing, registration and production of pharmaceutical products both in the US and EEC using both conventional and advanced drug delivery technologies.
Mai multe informatii http://www.smblab.be/index.php/about-s-m-b/company-profile/
Stratpharma is a pharmaceutical company founded in 2005 in Basel, Switzerland.
Stratpharma’s dermatology team has many years of international experience in the dermatological therapeutic franchise with a current focus on scars. These products for scar management and abnormal scar prevention can be used alone or in combination with other more invasive therapies. The current products including Strataderm® hold existing registrations and are available in over 38 countries in Europe, Africa, North America and Asia.
Stratpharma, in conjunction with its development partners, is extending its focus by developing a range of innovative products for topical dermatology. These new products will extend upon the immediate focus on scar and late stage wound healing.
Mai multe informatii http://www.stratpharma.com/about.html
Laboratori Farmaceutici Krymi is a Private Limited Company founded in 1994 in Rome, Italy, with an objective to formulate, produce and commercialize Cosmetics, Medical Devices and Pharmaceuticals targeted at the specialist sector. The technical know-how developed in their R&D laboratories coupled with the dedication of our specialized research staff has led to the development of an elevated number of innovative patented formulations with significant market potential.
The rigorous validation of the entire production process and the procedures put in place guarantee the high quality and safety standards of their products.
Mai multe informatii http://www.laboratorikrymi.com/about-us
PROGE FARM was founded in 1992 in Novara, Italy. In 2001 Proge Farm opened their own research laboratory to select probiotic bacteria, inside the Technology Centre of Novara. In the same year the laboratory obtained GLP certification (Good Laboratory Practice) from the Ministry of Health. Since 2010, PROGE FARM produces its bacterial strains in its GMP manufacturing plant.
In PROGE FARM’s laboratories, phenotypic and genotypic characterizations are developed and executed. All strains isolated by PROGE FARM are deposited at the Institute Pasteur in Paris (France) or at the Laboratorium voor Microbiologie in Gent (Belgium) and covered by Italian and international patents.
PROGE FARM works closely together with the University of Novara and has several collaborations with the scientific world, in particular with the University of Piemonte Orientale, University of Torino, University of the “Sacro Cuore” of Piacenza, the University of Pavia, the University of Bologna and the National Research Council (CNR).
Mai multe informatii http://www.progefarm.it/chi-siamo-en/#chi-siamo-a
Meditrina is a company with an inventive view for the marketing of medicines.
Well organized for the present, with perspective and certain strategy for future development of Rx drugs, medical devices, food supplements and cosmetics.
Mai multe informatii http://www.meditrina.gr/en/meditrina.html
Giellepi S.p.A. was founded in 1998 in Seregno, Italy. Giellepi’s core business concerns the study and development of innovative, science-based, ready-to-market food supplements, medical devices and medical foods for different medical needs. Over more than 15 years, the Ingredients and Health Science Divisions have gained great technical experience in developing proprietary finished formulation for the pharmaceutical industry and in distributing and creating innovative specialty ingredients.
Mai ulte informatii http://www.giellepi.it/
PH&T is an Italian pharmaceutical company engaged in research, development and production of generic drugs for specialist therapies, innovative medical devices and high quality food supplements, sold in more than 40 countries worldwide through licensees and distributors. The company was founded in Milan in 1991 with the aim of selecting and developing niche products, specialized in prescription products with a consolidated experience in oral slow release, sublingual formulations, eye drops, nasal spray and injectable forms.
Mai multe informatii http://www.phtpharma.com/
Professional Dietetics, founded in 1996 in Milan, Italy on particular biotechnological and managerial competences, devotes itself to study special mixtures of Amino Acids which stimulate protein syntheses. Professional Dietetics, through important researches and many scientific studies, has investigated the pathologies where protein syntheses are reduced, therefore the use of exclusive mixtures of Amino Acids is extremely effective and very helpful. Particularly, the carried out researches were focused on: peripheral insulin resistance, metabolic syndrome, type 2 diabetis mellitus, chronic heart failure, sarcopenia, wasting and cachexia, skin aging, chronic ulcers (diabetic foot, bedsores, etc.)
Mai multe informatii http://www.professionaldietetics.it/en/